Please try another search
Merck & Co., Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 15,775 million compared to USD 14,487 million a year ago. Net income was USD 4,762 million compared to USD 2,821 million a year ago. Diluted earnings per share from continuing operations was USD 1.87 compared to USD 1.11 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 14630 | 15962 | 15035 | 14487 |
Gross Profit | 10835 | 11731 | 11043 | 10590 |
Operating Income | 12 | 5824 | -4816 | 3951 |
Net Income | -1226 | 4745 | -5975 | 2821 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 106675 | 106727 | 104469 | 107796 |
Total Liabilities | 69040 | 65427 | 65727 | 60891 |
Total Equity | 37635 | 41300 | 38742 | 46905 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 246 | 7717 | 3704 | 1339 |
Cash From Investing Activities | 53 | -334 | -11443 | -2359 |
Cash From Financing Activities | -2245 | -4269 | 3758 | -2054 |
Net Change in Cash | -1760 | 2957 | -4074 | -2987 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review